Alcon Inc. (SWX:ALC)

Revance Therapeutics Revenue

Alcon had revenue of $2.47B USD in the quarter ending March 31, 2025, with 0.57% growth. This brings the company's revenue in the last twelve months to $9.93B, up 3.80% year-over-year. In the year 2024, Alcon had annual revenue of $9.91B with 4.82% growth.

• Revenue (ttm): $9.93B
• Revenue Growth: +3.80%
• P/S Ratio: 3.90
• Revenue / Employee: $387.71K
• Employees: 25,599
• Market Cap: 34.25B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.91B	456.00M	4.82%
Dec 31, 2023	9.46B	738.00M	8.47%
Dec 31, 2022	8.72B	426.00M	5.14%
Dec 31, 2021	8.29B	1.46B	21.34%
Dec 31, 2020	6.83B	-675.00M	-8.99%